Skip to main content
Equibles

Bank of New York Mellon Corp

Bank

Position in IBIO — iBio, Inc.

CIK 1390777 NEW YORK, NY
Back to IBIO Full portfolio

Position in IBIO

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$18,614
-$34,745 QoQ
Shares Held
10,637
+143.2% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 55 holders
Holding Since
Mar 2020
14 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Bank of New York Mellon Corp holds $4,864,365,655 across 311 Biotechnology names. IBIO ranks #302 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,672,623 $830,842,010
2 REGN
Regeneron Pharmaceuticals, Inc.
 758,492 $472,950,091
3 JAZZ
Jazz Pharmaceuticals plc
 1,578,013 $380,253,782
4 ALNY
Alnylam Pharmaceuticals, Inc.
 492,071 $148,128,128
5 INSM
INSMED Inc
 1,312,756 $139,966,036
6 MRNA
Moderna, Inc.
 1,701,675 $119,168,293
7 RVMD
Revolution Medicines, Inc.
 601,056 $112,565,759
8 INCY
Incyte Corp
 972,825 $110,279,435

All Filings in IBIO

Export CSV
14 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,614 10,637
2023-06-30 $53,359 87,474
2023-03-31 $183,156 88,056
2022-09-30 $22,034 129,616
2022-06-30 $33,700 129,616
2022-03-31 $310,086 721,132
2021-12-31 $406,597 739,269
2021-09-30 $771,188 727,537
2021-06-30 $922,366 610,839
2021-03-31 $787,071 511,086
2020-12-31 $449,066 427,683
2020-09-30 $391,722 192,967
2020-06-30 $350,446 157,859
2020-03-31 $49,365 46,571